JP2007526248A5 - - Google Patents

Download PDF

Info

Publication number
JP2007526248A5
JP2007526248A5 JP2006551541A JP2006551541A JP2007526248A5 JP 2007526248 A5 JP2007526248 A5 JP 2007526248A5 JP 2006551541 A JP2006551541 A JP 2006551541A JP 2006551541 A JP2006551541 A JP 2006551541A JP 2007526248 A5 JP2007526248 A5 JP 2007526248A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
polypeptide
amino acid
acid sequence
cell proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006551541A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007526248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002996 external-priority patent/WO2005072419A2/en
Publication of JP2007526248A publication Critical patent/JP2007526248A/ja
Publication of JP2007526248A5 publication Critical patent/JP2007526248A5/ja
Withdrawn legal-status Critical Current

Links

JP2006551541A 2004-01-27 2005-01-27 胃腸増殖因子およびその使用方法 Withdrawn JP2007526248A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US53960504P 2004-01-27 2004-01-27
US60/539,605 2004-01-27
US61924104P 2004-10-15 2004-10-15
US60/619,241 2004-10-15
PCT/US2005/002996 WO2005072419A2 (en) 2004-01-27 2005-01-27 Gastrointestinal proliferative factor and uses thereof

Publications (2)

Publication Number Publication Date
JP2007526248A JP2007526248A (ja) 2007-09-13
JP2007526248A5 true JP2007526248A5 (enExample) 2009-03-05

Family

ID=34830487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551541A Withdrawn JP2007526248A (ja) 2004-01-27 2005-01-27 胃腸増殖因子およびその使用方法

Country Status (14)

Country Link
US (4) US20050256044A1 (enExample)
EP (1) EP1727560B1 (enExample)
JP (1) JP2007526248A (enExample)
KR (1) KR20070007289A (enExample)
AU (1) AU2005208945A1 (enExample)
BR (1) BRPI0507168A (enExample)
CA (1) CA2554403A1 (enExample)
IL (1) IL177060A0 (enExample)
MX (1) MXPA06008495A (enExample)
NO (1) NO20063522L (enExample)
RU (2) RU2343158C2 (enExample)
SG (1) SG149059A1 (enExample)
TW (1) TW200536859A (enExample)
WO (1) WO2005072419A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2157192T1 (sl) * 2003-10-10 2013-11-29 Deutsches Krebsforschungszentrum Sestavki za diagnozo in terapijo bolezni, povezanih z aberantno ekspresijo Futrinov (R-Spondinov)
US20190330295A1 (en) * 2005-05-04 2019-10-31 Zealand Pharma A/S Glucagon-like-peptide-2 (glp-2) analogues
JP2009511017A (ja) * 2005-10-07 2009-03-19 ヌベロ インコーポレーティッド 幹細胞因子様タンパク質scfa1及びその使用
WO2008076556A2 (en) 2006-11-15 2008-06-26 Massachusetts Eye & Ear Infirmary Generation of inner ear cells
WO2008088524A2 (en) * 2006-12-28 2008-07-24 Nuvelo, Inc. Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor
SI2173379T1 (sl) 2007-07-02 2015-12-31 Oncomed Pharmaceuticals, Inc. Sestavki in postopki za zdravljenje in diagnosticiranje raka
US9464275B2 (en) 2008-08-21 2016-10-11 The Board Of Trustees Of The Leland Stanford Junior University Ex vivo culture, proliferation and expansion of intestinal epithelium
JP5809061B2 (ja) * 2008-11-24 2015-11-10 マサチューセッツ・アイ・アンド・イア・インファーマリー 有毛細胞を産生するための経路
SG173492A1 (en) 2009-02-03 2011-09-29 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising said stem cells.
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
RU2532323C2 (ru) * 2011-06-20 2014-11-10 Мапикс Эс.Эй.Ар.Эл. Лекарственное средство для лечения патологического синдрома и способ лечения функциональных нарушений кишечника
GB201106395D0 (en) * 2011-04-14 2011-06-01 Hubrecht Inst Compounds
MX349198B (es) 2011-07-15 2017-07-18 Oncomed Pharmaceuticals Inc * Agentes que se unen a las proteinas de r-espondinas (rspo) y usos de los mismos.
WO2014012007A2 (en) 2012-07-13 2014-01-16 Oncomed Pharmaceuticals, Inc. Rspo3 binding agents and uses thereof
JP2015527398A (ja) 2012-09-07 2015-09-17 マサチューセッツ アイ アンド イヤー インファーマリー 聴覚喪失治療
KR102133789B1 (ko) * 2013-01-10 2020-07-14 바이오콘 리미티드 유가식 모델을 이용한 피키아 파스토리스에서 재조합 단백질의 발현 방법
WO2016022776A2 (en) 2014-08-06 2016-02-11 Massachusetts Eye And Ear Infirmary Increasing atoh1 life to drive sensorineural hair cell differentiantion
EP3193935A4 (en) 2014-09-16 2018-03-21 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases
WO2016123474A1 (en) * 2015-01-30 2016-08-04 The University Of North Carolina At Chapel Hill Methods to generate gastrointestinal epithelial tissue constructs
US11185536B2 (en) 2015-12-04 2021-11-30 Massachusetts Eye And Ear Infirmary Treatment of hearing loss by inhibition of casein kinase 1
JP7080173B2 (ja) 2016-01-29 2022-06-03 マサチューセッツ アイ アンド イヤー インファーマリー 内耳支持細胞の拡大および分化ならびにその使用法
US11180735B2 (en) 2016-10-28 2021-11-23 The Board Of Trustees Of The Leland Stanford Junior University Methods to preserve tumor-stromal interactions in culture and therapeutic predictive applications thereof
TWI791539B (zh) 2017-06-16 2023-02-11 丹麥商西蘭製藥公司 用於投予類升糖素胜肽-2(glp-2)類似物的給藥方案
US12104149B2 (en) 2018-05-15 2024-10-01 The University Of North Carolina At Chapel Hill Devices, systems and apparatuses for generating self-sustaining hypoxic conditions and gaseous and non-gaseous chemical gradients for in vitro cell culture
JP7451427B2 (ja) 2018-05-25 2024-03-18 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 幹細胞/増殖細胞区画及び分化細胞ゾーンを有する平面腸陰窩のアレイの形成
CA3112220A1 (en) 2018-11-16 2020-05-22 The University Of North Carolina At Chapel Hill In vitro cell culture mucus systems
WO2021247497A1 (en) * 2020-06-03 2021-12-09 Children's Hospital Medical Center Compositions and methods comprising r-spondins for treatment of tumors
CA3219754A1 (en) 2021-05-21 2022-11-24 Gary Beale Microwave treatment of tissue
US12465781B2 (en) 2021-06-11 2025-11-11 Joon Bu Park Negative Poisson's ratio materials for thermal and radiation therapy seeds
WO2023097236A1 (en) * 2021-11-24 2023-06-01 The Rockefeller University Compositions and methods for generating immunoglobulin knock-in mice

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2198180C2 (ru) * 1994-10-13 2003-02-10 Амген Инк. Аналог природного фактора роста кератиноцитов (варианты), фармацевтическая композиция, рекомбинантная молекула нуклеиновой кислоты, кодирующая аналог, экспрессионный вектор, штамм e.coli, трансформированный вектором, способ получения аналога и способ стимулирования образования нефибробластных эпителиальных клеток
US6824973B2 (en) * 2000-02-03 2004-11-30 Kirin Beer Kabushiki Kaisha Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide
EP1268543A2 (en) 2000-04-05 2003-01-02 Kirin Beer Kabushiki Kaisha Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
US7411052B2 (en) * 2001-03-05 2008-08-12 Nuvelo, Inc. Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
US20030032034A1 (en) * 2001-03-05 2003-02-13 Tang Y. Tom Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
AU2002332767A1 (en) * 2001-08-30 2003-04-14 Nuvelo Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
EP1434796A2 (en) 2001-10-03 2004-07-07 Incyte Genomics, Inc. Secreted proteins
WO2003054152A2 (en) * 2001-12-10 2003-07-03 Nuvelo, Inc. Novel nucleic acids and polypeptides
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US20050054829A1 (en) * 2003-07-22 2005-03-10 Wiley Steven R. Compositions and methods relating to TSP-30a, b, c and d
US20050169995A1 (en) * 2003-10-03 2005-08-04 Kuo Calvin J. Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway
SI2157192T1 (sl) * 2003-10-10 2013-11-29 Deutsches Krebsforschungszentrum Sestavki za diagnozo in terapijo bolezni, povezanih z aberantno ekspresijo Futrinov (R-Spondinov)

Similar Documents

Publication Publication Date Title
JP2007526248A5 (enExample)
JPWO2019107530A5 (enExample)
JP2007515393A5 (enExample)
JP2011528333A5 (enExample)
JP2011528896A5 (enExample)
RU2006130791A (ru) Желудочно-кишечный пролиферативный фактор и его применения
JP2011528895A5 (enExample)
JP2018519366A5 (enExample)
MA32539B1 (fr) Traitement du diabète chez des patients pour lesquels une thérapie par la metformine n'est pas appropriée
JP2010534236A5 (enExample)
JP2011528897A5 (enExample)
JP2014513952A5 (enExample)
HRP20161458T1 (hr) Polipeptidi, polinukleotidi i pripravci namijenjeni upotrebi u liječenju latentne tuberkuloze
WO2011156453A3 (en) Therapeutic peptides
JP2010501596A5 (enExample)
JP2006506942A5 (enExample)
JP2013510169A5 (enExample)
JP2017532343A5 (enExample)
JP2009501801A5 (enExample)
JP2017221201A5 (enExample)
JP2018048151A5 (enExample)
JP2010536714A5 (enExample)
JP2011528334A5 (enExample)
JP2010500284A5 (enExample)
JP2010512326A5 (enExample)